Trazodone is not a hypnotic. It is classified as a SARI, a serotonin antagonist and reuptake inhibitor, which places it squarely in the antidepressant category. The FDA approved it in 1982 specifically for the treatment of major depressive disorder in adults, and that remains its only approved indication. However, trazodone is one of the most commonly prescribed medications for insomnia in the United States, used off-label at lower doses because of its strong sedating effects.
How Trazodone Differs From True Hypnotics
Sedative-hypnotics are a specific drug class designed to induce and maintain sleep. The classic examples are benzodiazepines and Z-drugs like zolpidem. These medications work by boosting the activity of GABA, the brain’s primary calming neurotransmitter. They increase chloride ion flow into nerve cells, essentially quieting the central nervous system.
Trazodone does something completely different. It blocks certain serotonin receptors and prevents serotonin from being reabsorbed by nerve cells. This is the mechanism that gives it antidepressant properties. The sedation is more of a side effect than a primary action. Antidepressants and antipsychotics typically cause drowsiness through blocking histamine H1 receptors, the same receptors targeted by over-the-counter sleep aids like diphenhydramine. Trazodone also blocks alpha-1 adrenergic receptors, which contributes to relaxation and lowered blood pressure.
Why It Gets Prescribed for Sleep
Despite not being a hypnotic, trazodone’s sedating properties are potent enough that many clinicians prescribe it for insomnia at doses well below those used for depression. Antidepressant doses typically range from 150 to 400 mg per day, while sleep doses are generally much lower, often in the 25 to 100 mg range. At these lower doses, the sedating receptor effects dominate while the antidepressant action remains minimal.
One major reason trazodone is favored over true hypnotics for sleep is its lower abuse potential. In controlled studies comparing trazodone to the benzodiazepine triazolam, subjects rated trazodone significantly lower on measures like “willing to take again,” a standard marker of abuse risk. Zolpidem, by contrast, produced abuse-related effects comparable to triazolam. This makes trazodone a practical alternative for people with a history of alcohol or substance use disorders who need help sleeping. Trazodone is also not a controlled substance, unlike benzodiazepines and Z-drugs, which are Schedule IV.
Effects on Sleep Stages
Trazodone changes your sleep architecture in ways that differ from traditional hypnotics. It increases the duration of slow-wave sleep, the deepest and most physically restorative stage. At the same time, it reduces the amount of time spent in REM sleep, the stage associated with vivid dreaming. Research published in the British Journal of Clinical Pharmacology found that people taking trazodone reported better subjective sleep quality, meaning they felt like they slept better, even though objective measurements of total sleep duration didn’t always show a significant increase.
One notable finding from that research: after stopping trazodone, there was a rebound effect. Slow-wave sleep dropped below baseline levels temporarily, while REM sleep bounced back above normal. This suggests the body adjusts to trazodone’s influence on sleep stages, and stopping abruptly can temporarily disrupt your sleep pattern.
Side Effects That Matter
The same receptor-blocking activity that makes trazodone sedating also causes some side effects worth knowing about. Blocking alpha-1 adrenergic receptors lowers blood pressure, which can cause orthostatic hypotension, that lightheaded feeling when you stand up too quickly. For most younger adults, this is a mild nuisance. For older adults, it can be a real problem.
A study in Drugs & Aging examined geriatric outpatients with high blood pressure and found that trazodone users experienced a systolic blood pressure drop roughly 9.5 mmHg greater than non-users upon standing. The clinical consequences were striking: 58.3% of trazodone users experienced syncope (fainting) or falls, compared to 21.2% of those not taking the drug. Trazodone use independently predicted falls regardless of age, disability level, or prior fall history. If you’re older or already take blood pressure medication, this is a particularly important consideration.
Trazodone also carries a rare but serious warning for men: priapism, a painful erection lasting more than six hours. Because cases are reported voluntarily after the drug reaches market, the exact incidence rate isn’t well established, but the risk is significant enough that the FDA label includes a prominent warning. An erection lasting more than four hours requires emergency medical attention, as untreated priapism can cause permanent damage to erectile tissue.
Common, less serious side effects include morning grogginess, dry mouth, and dizziness. Because trazodone has a relatively short duration of action, the hangover effect the next morning tends to be milder than with longer-acting sleep medications, though it varies by dose and individual metabolism.
The Bottom Line on Classification
Trazodone is an antidepressant with strong sedating properties, not a hypnotic. The distinction matters because its mechanism, safety profile, and regulatory status are all different from true sedative-hypnotics. It works on serotonin and histamine pathways rather than the GABA system. It carries no controlled-substance scheduling and poses less risk for dependence. But it also comes with its own set of side effects, particularly blood pressure drops and, rarely, priapism, that traditional hypnotics don’t cause. Its widespread use for insomnia is entirely off-label, meaning the FDA has never formally evaluated and approved it for that purpose, even though millions of prescriptions are written for exactly that reason every year.